ADIL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 23:00):

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders...

Stats
Šios dienos apimtis	236 415
Vidutinė apimtis	6.52M
Rinkos kapitalizacija	6.89M
EPS	$-1.154 ( 2024-04-04 )
Kita pelno data	( $-0.510 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.350
ATR14	$0.0150 (0.88%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Gilliland Robertson H.	Buy	12 000	Stock Option (Right to Buy)
2024-03-25	Newman James W. Jr.	Buy	12 000	Stock Option (Right to Buy)
2024-03-25	Truluck Joseph	Buy	25 000	Stock Option (Right to Buy)
2024-03-25	Claiborne Cary J	Buy	60 000	Stock Option (Right to Buy)
2024-03-25	Anderson J. Kermit	Buy	12 000	Stock Option (Right to Buy)

INSIDER POWER
91.12
Last 98 transactions
Buy: 7 510 922 \| Sell: 1 943 977

Tūris Koreliacija

Ilgas: -0.10 (neutral)

Trumpas: -0.74 (moderate negative)

Signal:(46.192) Neutral

Adial Pharmaceuticals Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
EXFY	0.967
ELEV	0.966
DRVN	0.965
GSIT	0.964
TSVT	0.963
CMBM	0.958
FGEN	0.956
IPGP	0.956
CMCT	0.952
NNOX	0.951

10 Labiausiai neigiamai susiję koreliacijos
NVAC	-0.958
PRDO	-0.955
MITA	-0.952
GHIXU	-0.943
WFRD	-0.939
BRIVU	-0.938
MSDA	-0.938
CCRC	-0.935
MMYT	-0.932
DSEY	-0.931

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Adial Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos

0.17
( neutral )

-0.24
( neutral )

0.00
( neutral )

-0.50
( neutral )

0.07
( neutral )

Adial Pharmaceuticals Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-564.00 (0.00 %)
EPS:	$-5.44

FY	2023
Pajamos:	$0
Bruto pelnas:	$-564.00 (0.00 %)
EPS:	$-5.44

FY	2022
Pajamos:	$0
Bruto pelnas:	$-60 501.00 (0.00 %)
EPS:	$-317.81

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-1.971

Financial Reports:

No articles found.

Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.